ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Nephrology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,476Medicare Part D Prescriptions Filled, Including Refills

Rank: 6 out of 88

$288K Total Retail Price of All Prescriptions

Rank: 35 out of 88

431 Patients Receiving at Least One Drug in Part D
60%Patients 65 Years and Older
78% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

39% of this provider’s 431 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

5% of this provider’s 4,069 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $103 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
HYDROCODONE-ACETAMINOPHEN 480 217 S3 1 10
OMEPRAZOLE 214 130 2 8
SIMVASTATIN 173 113 3 9
LISINOPRIL 170 123 4 3
CLONIDINE HCL 167 129 5 7
LEVOTHYROXINE SODIUM 149 81 6 16
POTASSIUM CHLORIDE 139 113 7 32
NEXIUM 128 85 8 22
FUROSEMIDE 108 74 9 2
CYCLOBENZAPRINE HCL 105 74 R 10 53
METOPROLOL SUCCINATE 105 92 10 33
RANITIDINE HCL 104 63 12 36
AMLODIPINE BESYLATE 101 67 13 1
METOPROLOL TARTRATE 94 57 14 12
ZOLPIDEM TARTRATE 80 58 15 24
TAMSULOSIN HCL 74 62 16 29
GLIMEPIRIDE 72 30 17 38
NIFEDIPINE ER 72 62 17 35
DOXAZOSIN MESYLATE 70 45 19 41
BUMETANIDE 69 59 20 30
ATENOLOL 67 29 21 28
KLOR-CON 10 67 40 21 89
CARBIDOPA-LEVODOPA 67 51 21 127
ISOSORBIDE MONONITRATE ER 67 62 21 47
HYDROCHLOROTHIAZIDE 65 57 25 25
MELOXICAM 64 38 26 70
TRAZODONE HCL 64 0 26 59
AMITRIPTYLINE HCL 63 27 R 28 64
GABAPENTIN 63 45 28 23
CARISOPRODOL 60 0 R 30 135
FLUOXETINE HCL 57 23 31 75
CITALOPRAM HBR 57 31 31 55
LISINOPRIL-HYDROCHLOROTHIAZIDE 57 33 31 50
POLYETHYLENE GLYCOL 3350 52 45 34 147
CARVEDILOL 52 31 34 6
PHENYTOIN SODIUM EXTENDED 52 24 34 147
METFORMIN HCL ER 51 16 37 108
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.